Pre-made Enfortumab Vedotin benchmark antibody (Whole mAb ADC, anti-PVRL4/NECTIN4 therapeutic antibody, Anti-EDSS1/LNIR/PRR4/nectin-4 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-833

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-833 Category Tag

Product Details

Pre-made Enfortumab Vedotin benchmark antibody (Whole mAb ADC, anti-PVRL4/NECTIN4 therapeutic antibody, Anti-EDSS1/LNIR/PRR4/nectin-4 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Enfortumab Vedotin Biosimilar, Whole Mab Adc, Anti-PVRL4/NECTIN4 Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic antibody Drug Conjugate

INN Name

enfortumab vedotin

Target

PVRL4

Format

Whole mAb ADC

Derivation

Human

Species Reactivity

Human

CH1 Isotype

IgG1 – kappa

VD LC

IgG1 – kappa

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

Seattle genetics, Inc. (Bothell WA USA) / Agensys (Santa Monica CA USA) / Astellas Pharma?US,?Inc. (Northbrook IL USA)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

PVRL4

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide